Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia
- 31 October 1996
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 129 (4) , 551-558
- https://doi.org/10.1016/s0022-3476(96)70120-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Antibodies to myeloid precursor cells in autoimmune neutropeniaBlood, 1994
- New Developments in the Treatment of NeutropeniaArchives of Pediatrics & Adolescent Medicine, 1993
- Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factorJAMA, 1993
- A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropeniaBlood, 1993
- Autoimmune neutropenia [see comments]Blood, 1993
- Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with chronic benign granulocytopenia and congenital agranulocytosis (Kostmann's syndrome)Acta Paediatrica, 1992
- Chronic Neutropenia During ChildhoodAmerican Journal of Diseases of Children, 1991
- Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropeniaBlood, 1990
- Effects of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutropenia in Patients with Congenital AgranulocytosisNew England Journal of Medicine, 1989
- Intravenous treatment with γ-globulin of autoimmune neutropenia of infancyThe Journal of Pediatrics, 1988